Funds and ETFs Bio-Techne Corporation

Equities

TECH

US09073M1045

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
63.52 USD -0.27% Intraday chart for Bio-Techne Corporation -0.77% -17.68%

ETFs positioned on Bio-Techne Corporation

Name Weight AuM 1st Jan change Investor Rating
2.93% 1 M€ 0.00% -
2.50% 5 M€ -1.80% -
2.15% 2 M€ -.--%
1.25% 0 M€ 0.00% -
1.13% 0 M€ 0.00% -
0.74% 7 M€ -.--% -
0.54% 18 M€ +4.24% -
0.36% 267 M€ +6.51%
0.35% 2 M€ +5.19%
0.17% 9 M€ -.--% -
0.16% 105 M€ +5.78%
0.12% 5 M€ -72.95% -
0.12% 10 M€ +5.63%
0.12% 8 M€ +3.59% -
0.12% 33 M€ +0.60% -
0.12% 18 M€ +3.59% -
0.08% 2,510 M€ +10.64%
0.07% 1,448 M€ -.--% -
0.07% 219 M€ +17.17% -
0.06% 330 M€ -.--% -
0.06% 2 M€ +14.69% -
0.06% 277 M€ -.--% -
0.06% 194 M€ +5.24% -
0.06% 441 M€ +8.99%
0.05% 276 M€ +11.40% -
0.05% 9 M€ +1.29% -
0.05% 736 M€ +6.53%
Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sales break down by family of products as follows: - biological and chemical reagents and analysis tools (74.3%): proteins, antibodies, molecules, culture serums, tools for cell work, tools for the study of proteins, immunoassay tools, etc.; - diagnostic and genomics products (25.7%): reagents and products used in blood analysis, nucleic acid analysis, tissue biopsy, gene analysis, cancer and genetic carrier screening, etc. Net sales are distributed geographically as follows: the United States (56.5%), the United Kingdom (4.4%), Europe/Middle East/Africa (19.4%), China (10%), Asia/Pacific (6.4%), and other (3.3%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
63.52 USD
Average target price
80.43 USD
Spread / Average Target
+26.63%
Consensus
  1. Stock Market
  2. Equities
  3. TECH Stock
  4. Funds and ETFs Bio-Techne Corporation